Dr. Jonathan Javitt
Founder, Chairman & CEO
Replay available
NRX Pharmaceuticals, Inc. (NRXP) Q4 2025 Earnings Call
NRX Pharmaceuticals, Inc. (NASDAQ: NRXP) Q4 2025 earnings conference call, held 2026-03-24. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Edward Wu
Analyst, Ascendian Capital
Patrick Truccio
Analyst, HC Wainwright
Michael Abrams
CFO
Tom Schrader
Analyst, BTIG
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Nrx Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:22.357 -- 00:00:24.357 Thank 00:00:26.298 -- 00:00:28.298 you. 00:01:39.610 -- 00:01:41.610 ¶¶ 00:02:18.642 -- 00:02:20.642 We'll 00:02:26.572 -- 00:02:28.572 be 00:02:28.835 -- 00:02:30.835 right 00:02:32.579 -- 00:02:34.579 back. 00:02:54.620 -- 00:02:56.444 Thank 00:02:56.444 -- 00:02:58.444 you. 00:04:21.425 -- 00:04:23.425 Thank 00:04:24.036 -- 00:04:26.036 you. 00:04:58.246 -- 00:05:02.068 We'll be right 00:05:05.415 -- 00:05:07.415 back. 00:05:53.107 -- 00:05:55.107 Thank 00:05:55.155 -- 00:05:57.155 you. 00:06:28.510 -- 00:06:34.137 Good morning, ladies and gentlemen, and welcome to the NRX Pharmaceuticals Q4 2025 00:06:34.137 -- 00:06:38.743 Results Conference Call. At this time, all lines are in listen-only mode. 00:06:38.743 -- 00:06:42.788 Following the presentation, we will conduct a question and answer session. 00:06:42.788 -- 00:06:46.954 If at any time during this call you require immediate assistance, please press star zero 00:06:46.954 -- 00:06:52.341 for the operator. This call has been recorded on Tuesday, March 24, 2026. 00:06:52.341 -- 00:06:57.307 I would now like to turn the conference over to Michael Abrams, CFO. 00:06:57.307 -- 00:06:59.728 Please go ahead. 00:07:00.370 -- 00:07:05.416 Thank you, Joelle, and welcome, everyone. Before we proceed with the call, I 00:07:05.416 -- 00:07:09.382 would like to remind everyone that certain statements made during this call are forward-looking 00:07:09.382 -- 00:07:13.106 statements under the United States Federal Securities Laws. 00:07:13.106 -- 00:07:17.192 These statements are subject to risks and uncertainties that could cause actual results 00:07:17.192 -- 00:07:21.517 to differ materially from historical experience or present expectations. 00:07:21.517 -- 00:07:26.753 Additional inf...